migraine treatment [12] that possibly can also be explored for neuromodulation in cluster headache [13] , though we will focus mostly on migraines.
A brief note on the history is due. Despite the fact that the elds of translational computational neuroscience and neuromodulation are still in their relative infancy, let alone their fusion, they both actually have a long partly overlapping history. Neuromodulation for example in form of non-drug treatment in headache dates back to the mid-first century CE to Scribonius Largus, a physician who practiced at the court of the Roman Emperor Claudius and who recognized the seemingly bene cial e ects of discharges from electrical sh in headache [14] . Not astonishingly, these primitive neuromodulation concepts gained much new interest in the [15] . The modern aspects of this eld with some further notes on the history have been recently described in the textbook entitled "Neural control engineering: the emerging intersection between control theory and neuroscience" [16] .
In the following, we first briefly introduce dynamical network biomarkers (Sec. 2) and then adapt the concept DNB to chronic disorders with episodic manifestations (Sec.
3) and highlight migraine as an example (Sec. 4). To this end, we introduce migraine theories (Sec. 5) and computational models of spreading depression (Sec. 6) on microscopic and macroscopic scale where the concept of DNB must be applied. We end with an overview of neuromodulation and concluding remarks (Sec. 7).
Dynamical network biomarkers
Traditional biomarkers are some objectively measured and evaluated indicators of a particular biological state that occurs in association with a pathological process.
Usually static measurements of some traceable substances are called biomarkers. Also genetic biomarkers exist, de ned as mutations or polymorphisms that predict some clinically relevant measure for example risk of disease, its outcome or response rate to treatment.
In contrast, a DNB is a dynamical feature of a biological network under consideration.
Such features were originally suggested to be of particular interest in complex diseases with sudden deterioration phases or critical transition points during their progressions [4, 5] . Depending on the progression level of such disorders three stages are distinguished: a normal state, a critical pre-disease state, and a disease state ( Figure 1 ). The normal state is a steady state with functional homeostatic control, representing a (relatively) healthy stage yet maybe in an incubation period. The critical pre-disease state is still clinically silent and is considered as the state just before the first clinical onset. Mathematically, the critical pre-disease state is defined as the limit of the normal state immediately before a well-defined tipping point is reached. Finally, the disease state is with control failure but otherwise, in particular from a mathematical perspective, also simply a stable state.
A DNB is essentially a group of traceable substances or, in general, signals that while highly fluctuating are strongly correlated only during the pre-disease stage. Therefore a DNB is di erent from the conventional biomarkers in two ways. First, it is not required for DNBs to keep consistent values for the respective disease and normal samples. Only the presence of highly fluctuating and strongly correlated signals is important. Second, the aim of DNB is to detect the pre-disease state, i.e., earlywarning signals associated with the imminent tipping point, but not to distinguish the respective disease and normal states.
If the pre-disease state is detected by a DNB, early treatment can be started, see Figure 1 . It was first analytically shown that a DNB serves as an early-warning signal by defining particular but rather abstract critical states as coherent subnetworks that were then recognized as the physiological correlate of the pre-disease state. DNBs were successfully identified in Figure 1 . Schematic illustration of the dynamical features of disease progression from a normal state to a disease state through a pre-disease state (modified from [4] ). (a)
The normal state is a steady state or a minimum of a potential function, representing a relatively healthy stage. (b) The pre-disease state is situated immediately before the 'tipping point' . At this stage, the system is sensitive to external stimuli and still reversible to the normal state when appropriately interfered with. A small change in the parameters of the system may suffice to drive the system into collapse, which often implies a large phase transition to the disease state. When the system approaches the pre-disease state, the deviations of the set of nodes (3, 4, 7) increase drastically, and the correlations (positively or negatively) among them also increase drastically whereas their correlations with other nodes (1, 2, 5, 6) decrease drastically. We call (3, 4, 7) the DNB. (c) The disease state is the other stable state or a minimum of the potential function, where the disease has seriously deteriorated and thus the system is usually irreversible to the normal state. medicine for lung injury disease, liver cancer, and lymphoma cancer [4, 5] . is not a prediction in these cases but rather one possible a posteriori explanation for the prodrome.
Chronic disorders with episodic manifestations -dynamical systems theory view
The cycle of recurrent episodic manifestations is illustrated in a simpli ed way in Figure 2 . by their premonitory prodromal symptoms [19] . Thus, the broadened aim is to use the understanding of the slow and still gradual physiological changes in the prodrome to prevent the imminent abrupt attack, that is, to quantify the prodrome by DNB to construct a biofeedback signal for therapeutic control techniques.
Primary headaches as examples
The theoretical concept of early-warning signals is independent of its application [3] and the concept of DNB is actually a modelfree concept [4, 5] . Still specifi c computational models are needed to approach the broadened aim of therapeutic strategies. We cannot outline the potential use of DNB as early-warning signals in general terms and therefore focus on primary headaches and in particular on migraine. Migraine patients can very often correctly predict with premonitory symptoms their attacks [19] and various neuromodulation methods are today available to treat headaches [13] . Furthermore, computational models of migraine exist and describe the complex processes on a wide range of time and space scales, see Figure 4 .
Migraine is a primary headache disorder characterized by recurrent episodes of head pain, often throbbing and unilateral sometimes preceded by neurological symptoms called aura. The known pathophysiologic mechanism suggests that this disorder should be considered as a neurovascular headache [20] .
Migraine is a highly disabling disorder being according to the World Health Organization the seventh most disabling in the world and the fourth most disabling among women.
Cluster headaches are also a primary headache disorder and the brainstem structures and subnetworks discussed below are also involved in cluster headache so that these concepts can likely be applied in some form to cluster headache, too.
Note that migraine is a chronic disorder with episodic manifestation, also referred to as episodic migraine, while the relative new term 'chronic migraine' (CM) refers to chronifi cation of the recurrent attacks, that is, more than 15 headache days per month over a 3 month period, at least 8 migrainous, and in the absence of medication overuse.
In migraine without aura (MO), attacks are usually associated with nausea, vomiting, sensitivity to light (photophobia) and sound (phonophobia), and attacks are worsened by movement. Migraine with aura (MA) involve in addition-but also rarely exclusivelyneurologic symptoms (called aura) [21] .
Migraine aura symptoms are most often visual field disturbances, but affect also other sensory modalities or cognitive functions [22] . Aura symptoms are caused by a wave of cortical spreading depression. Whether this wave also contributes to the headache phase in migraine is currently debated [23] .
Epidemiological studies suggest that MA and MO share the same headache phase.
However, on average the pain seems to be less severe and shorter lasting in MA than in MO [24] . to be not related to blood pulsation but is a signature of rhythms in the brain [25, 26] . 
Migraine theories
While we expect that quantitative methods such as computational neuroscience will become increasingly important in migraine research to keep up with the proliferation of imaging data and to con ne current theories, it was the advent of non-invasive imaging that changed the view on this headache type in the rst place with some intriguing qualitative observations. In the 1980s and into the mid-1990s, it became clear by studies of the clinical features of migraine and its physiological mechanisms that there is no clear correlation between blood flow changes and the headache but instead imaging studies suggested [28] that upstream events in the brainstem named 'migraine generator' (MG) [29] lead to the cascade resulting in migraine pain. Furthermore, imaging migraine with aura revealed that the phenomenon of cortical spreading depression (SD) is the neural correlate of migraine aura [30, 31] . To date, the MG and SD theories are facing each other but are probably not irreconcilable.
In brief, the MG theory states that a dysfunction of the brainstem causes the pain and via further connections (directly and indirectly) the brainstem is also responsible for the neurological changes before the headache phase including symptoms in the prodromal phase and the aura phase, in particular, the MG is causing SD via a failure of vasomotor control ( Figure 4d ). The SD theory of migraine assumes that this cortical wave causes the neurological systems (aura) [32] and it can also cause the pain in the headache phase, which usually occur after the aura phase, but cf. [33] .
In this theory, two independent pathways This is supported by the e cacy of calcitonin gene-related peptide receptor antagonists at the level of these neurons in migraine therapy [35] (central pathway, Figure 4f ). Probably, a combination of the peripheral and central pathway leads to this complex disorder and quantitative models as outlined below can help to disentangle the relative contributions and dependencies.
Computational models in migraine
Computational models of spreading depression date back to the mid-1970s. A simple rule-based cellular automata model was used to mimic the two-dimensional spread on the cortical surface, including spiral-shaped SD waves reentering around a functional block [36] that can also be observed experimentally [37] . Partial di erential equations were used to describe the detailed physiological cellular events [38] .
For a detailed review of SD modeling, including the mathematical description, see the excellent review by Miura et al. [39] . In the following, only basic approaches focusing on the principles of cellular dynamics and tissue pattern formation in SD are introduced. We start with cellular dynamics of SD and continue with the events in cortical tissue. The mathematical equations are given in an Appendix.
Cellular dynamics in SD
The focus in computational models of the cellular dynamics in SD is on transmembrane events that can be observed in in vitro experiments [40] . The advantage of such experiments is that the phenomenon of SD can be studied in isolation and the complex vasomotor feedback involved in SD can be neglected [41] , though current modeling approaches include metabolic and perfusion effects on SD [42] . With this local focus set, SD is essentially a massive but temporary perturbation of ion homeostasis. The ion With an ion-conductance-based model of a total of 9 dynamical variables the main features of SD that happen across the cell membrane can be modeled (see Figure 4b ).
Using electroneutrality and further symmetry Of all these events highlighted in Figure 4b most notably is the recovery phase of SD at around 24.5 s. According to the computational models, recovery is due to a deactivation of the sodium activator m driven by a dominat I Na that actually repolarizes V shortly after the seizurelike firing stops due to a depolarization block.
After the deactivation of the sodium activator Next, we consider large-scale tissue events caused by SD. But before that it is worthwhile noting that cellular models often do not include lateral space, except for the original work by Miura and Tuckwell [38] and some recent approaches from the group of Miura [48] and an isolated work by Shapiro [46] considering osmotic forces and gap junctions.
The compartments mentioned before extend in the vertical direction to model the apical dendritic tree of pyramidal cells in the cortex [45, 47] . But the very detailed models by Kager, Wadman, and Somjen are not spatially extended to describe the lateral extension, that is, they describe SD not as an excitable phenomenon in a spatially extended system, called excitable media.
The lateral extension of cellular SD models is far from straight forward. Naively adding di usion to the extracellular dynamical ion concentrations yields some insights but it does not reflect the necessary detail of neural microcircuits that needs to be considered to take the spatial continuum limit (Figure 4c ).
Neural eld models, for example, describe this limit for rate-or activity-based neural mass models [49] . The problem is that the neural tissue is heterogeneous and the cell's 
Tissue events caused by SD
The Gibbs free energy-depleted and activity depressed state of SD described in the former section can spread through gray matter tissue by electrodi usion due to newly formed ion gradient along the membranes in the neuronal and glial syncytium and the interstitial volume.
In accordance with noninvasively imaged SD progression using high-field functional magnetic resonance imaging (fMRI) [31] and reported visual eld defects [51] , a macroscopic computational model of SD (see Appendix B) was proposed in which to each episodic migraine attack a particular spatio-temporal SD pattern is formed [12, 52] . With this model a mechanism was suggested to explain the shape of SD in migraine as a discontinuous
wave segment that spreads out in only one direction. In a nutshell, the mechanism is based on dissipative structures as self-organized localized solitary patterns [53, 54] that become transient objects with critical slowing down-from a mathematical point of view a mechanism similar to the one of DNB-that is modulated by cortical folding, see Figure 3 .
These are the tissue events of SD that are of clinical importance for migraine because we predict that they will determine not only the migraine aura but also the headache phase without infarct) to re-entrant waves (stroke) [57] . Therefore, the precise spatio-temporal SD pattern formation is of immense clinical interest [58] .
To simulate the clinically observed patterns in migraine [31, 51] , a generic reaction-diffusion mechanism can be described in abstract terms of activator-inhibitor kinetics. In fact, simple activator-only kinetics date back to a mechanism of SD described in 1963 by model [59] . The GHH model assumed that the extracellular potassium ion concentration is an activator in SD. We extended this scheme by introducing two inhibitory mechanisms, an immobilized inhibitor and a mean eld inhibition (for details of the full model see [52] ). 
Concluding remarks on translating theoretical concepts into neuromodulation applications
The design of new neuromodulation strategies in migraine requires to understand how electric and magnetic stimulation changes neural activity. Even more important are quantitative models of the network dynamics during this neurological condition to optimize stimulation protocols. In Sec. 6.1, we described cellular dynamics that are key to understand how electric and magnetic stimulation influences brain activity. The cellular dynamics are also the microscopic foundation of self-organized macroscopic tissue events, which are of direct clinical relevance. In Sec. 6.2, we show that on the macroscopic level SD manifests as a localized wave in the human cortex during migraine with aura. From the model we can predict that the macroscopic spatio-temporal SD patterns (shape, size, and duration) determine to some extent the clinical manifestation of a migraine attack [12] .
As we argued in Sec. 5, the spatio-temporal SD events can determine the amount of noxious input into the pain sensitive structures (Figure 4e ) as well as modulate corticothalamic feedback loops (Figure 4f ) . However, the question about the most upstream event in the course of a migraine attack that would directly lead to the optimal target of preventative intervention is probably too naive. The ignition of SD is currently unknown but a failure of vasomotor control from the brainstem, which is part of the MG theory, is a likely scenario (Figure 4d ). It further is plausible that these SD waves will in turn also affect the brainstem activity because SD itself causes a complex vasomotor reaction [41] .
This allows only one conclusion: Migraine is an
inherently dynamical disease with a complex network of interdependent events rather than a disease with a linear course from upstream to downstream events, a course that is also called into question by a rather variable cycle of recurrent episodic symptoms in migraine with phases such as the aura that occurs only in a fraction of the individual attacks [60] .
The central question therefore is about di erent brain structures and in which phase of the migraine cycle they are promising neuromodulation targets ( Figure 5 ) in the framework of complex dynamical systems and control theory [8] . We still lack a unified quantitative model combining the events in SD theory and MG theory of migraine (Sec. 5) to interpret their relation, simulate the impact of potential neuromodulation intervention, and make concrete predictions about optimized
stimulations protocols that can be tested.
In this situation, however, the theoretical framework of DNBs provides a sound basis to address these challenges because DNBs are based on a model-free concept and, if DNBs can be identi ed in migraine, they will help to develop a unified theory. Namely, DNBs will not only show whether a symptom is approaching or not, but also help to construct such a uni ed model explaining how the symptom appears, and providing a feedback-control-scheme to suppress the symptom.
We end this review by introducing briefl y two neuromodulation techniques that are currently investigated in migraine in two di erent phases of the migraine cycle targeting two di erent brain structures. Then, we speculatively suggest a promising third neuromodulation technique that may be of particular use during the prodromal phase that could refl ect a DNB (cf. Sec. 3). Furthermore, we also suggest taking the attack-free interval into account for prophylactic intervention.
Note that, as of to date, there is no approved indication for neuromodulation with electric or magnetic stimulation for episodic but only for chronic migraine (>15 headache days per month). In fact, due to the severeness of pain, most neuromodulation studies in headache research are or have been conducted among patients with refractory cluster headache.
However, the eld is rapidly increasing [13] and
given that newer devices require noninvasive or Figure 5 .
In a recent study, the stimulation was tested with biphasic rectangular AC impulses at 60Hz.
The therapeutic gain (26%) is within the range of those reported for other preventive drug and nondrug migraine treatments [61] . The Figure 5 . The results (eff ective in aborting migraine attacks) of this sham-controlled study were promising, i.e., it seems to disrupt SD, but that would limit its use to the acute aura phase.
However, considering the concept of silent aura Figure 5 . Various neuromodulation techniques are currently investigated in chronic migraine, but note that, as of to date, there is no approved indication for neuromodulation with electric or magnetic stimulation for episodic migraine. We suggest to investigate these techniques also in episodic migraine and to use quantitative models and modern control theory to determine an optimal stimulation protocol, 
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DNB? [63] and the mathematical model for SD [52] , 
Sphenopalatine ganglion stimulation
Beside the two mechanism explained by the SD theory (Figure 4e, f (1)
The variable V is the potential di erence or voltage across the membrane relative to the grounded extracellular side. The cell membrane has a capacity C m . The currents I ion are the transmembrane currents with ion ∈{Na + ,K + ,Cl − }.
I app is an externally applied current. These are given by (4) for p∈{n,m,h}.
Reaction-diffusion models
To simulate the clinically observed patterns in migraine [31, 51] , a generic reaction-diffusion mechanism can be described in abstract terms of activator-inhibitor kinetics of just two variables u and v, respectively. We extended the GHH model (see the main text) in the following way (also for details of the full model see Ref.
[52]): 
